Annual Drug Patent Expirations for ROCKLATAN
Rocklatan is a drug marketed by Aerie Pharms Inc and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.
This drug has fifty-eight patent family members in nine countries.
The generic ingredient in ROCKLATAN is latanoprost; netarsudil dimesylate. One supplier is listed for this compound. Additional details are available on the latanoprost; netarsudil dimesylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com